Dina Matos joined CARES Foundation, a not-for-profit organization dedicated to serving the needs of individuals affected by congenital adrenal hyperplasia (CAH) worldwide, as Executive Director in 2009. During her tenure, CARES completed its first strategic planning initiative, updated its website and logo, published guidelines for the development of centers of excellence for congenital adrenal hyperplasia, designated eight centers of excellence across the United States and collaborated on the development of CAHtalog, a CAH registry.  Education, research and awareness remains a top priority for Dina.  Under her leadership, CARES  has significantly expanded its support network, increased educational opportunities, intensified research initiatives, increased advocacy for treatment options, and initiated awareness walks across the country. Her work in the health care industry spans more than three decades.

CARES Foundation, Inc. is a nonprofit organization based in the USA that leads in the effort to improve the lives of the Congenital Adrenal Hyperplasia (CAH) community and seeks to advance quality health care. Through support, advocacy, education, and research represents nearly 8,000 affected individuals, families, and healthcare professionals in the United States and more than 70 countries. CARES provides access to expert care in CAH through physician referrals, an ASK THE EXPERT online service, and eight CARES-designated centers of excellence for CAH across the United States. We offer a variety of patient, caregiver, and family support, as well as several educational opportunities. We strive to advocate for treatment options, patient rights and awareness of CAH. CARES supports research for new and better treatment options, for improved quality of life for patients, and ultimately a cure.  Now in our 3rd decade in service to the CAH community, we continue to grow to help patients live healthier and fuller lives. For more information, visit caresfoundation.org.

Spruce Biosciences is developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need.  New this year, Spruce is introducing a quarterly, educational webinar series for patients living with rare endocrine disorders and their caregivers. We strive to support the endocrine community by providing answers to your questions with responses from experts in the field, sharing tips to navigating conversations with healthcare providers, compiling resources that address unmet needs and other concerns associated with the disorders, and furnishing tools that help you make informed choices regarding treatments and clinical trial participation. For more information visit sprucebiosciences.com.